Related Experiment Video
Updated: Jul 6, 2026

Implementing Patch Clamp and Live Fluorescence Microscopy to Monitor Functional Properties of Freshly Isolated PKD Epithelium
Published on: September 1, 2015
Enema-induced severe hyperphosphatemia in children
Ariane Biebl1, Andrea Grillenberger, Klaus Schmitt
1Department of Pediatrics, Children's Hospital, Linz, Austria. ariane.biebl@gespag.at
Insights
Phosphate enemas can cause severe toxicity in children, contrary to popular belief. This case highlights the risks for children with developmental delays and chronic constipation.
Area of Science:
- Pediatric Gastroenterology
- Clinical Toxicology
Background:
- Phosphate-containing enemas are commonly used for pediatric constipation.
- Children with developmental delay often experience chronic constipation and bowel dysfunction.
Observation:
- A 13-year-old boy with Costello syndrome and chronic constipation received multiple phosphate enemas.
- Within 24 hours, he developed severe hyperphosphatemia, hypertonic dehydration, and hypocalcemia.
Findings:
- Phosphate enemas can be systemically absorbed, leading to severe toxicity.
- This case demonstrates potentially lethal complications of phosphate enema use.
Implications:
- Physicians must recognize the risks associated with phosphate enemas, especially in high-risk pediatric patients.
- The assumption of systemic inactivity of these enemas is incorrect and dangerous.
Abstract:
We report the case of a 13-year-old boy with Costello syndrome and chronic constipation who received phosphate-containing Fleet-pediatric enemas at regular intervals. The day before admission he was given four enemas for severe constipation. Within 24 h the boy had developed severe hyperphosphatemia (phosphate 17.75 mmol/L), hypertonic dehydration (sodium 171 mmol/L) and severe hypocalcemia (calcium 0.56 mmol/L). With early intervention and treatment, the child survived without sequelae. Osmotically acting hypertonic phosphate enemas may result in severe toxicity. Children with developmental delay often display bowel dysfunction and chronic constipation and are therefore high-risk patients. The accepted opinion-that these enemas are not absorbed and therefore systemically inactive-is not true. Physicians should be aware of the potentially lethal complications of this treatment, which is part of everyday clinical practice.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Peritoneal Dialysis III: Nursing Management
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Introduction to Electrolytes
Role of Sodium
One...
